FreeCast, Inc. (CAST)
NASDAQ: CAST · Real-Time Price · USD
2.320
-0.030 (-1.28%)
Apr 23, 2026, 10:10 AM EDT - Market open
FreeCast Market Cap
FreeCast has a market cap or net worth of $94.79 million as of April 23, 2026.
Market Cap
94.79M
Enterprise Value
98.34M
1-Year Change
n/a
Ranking
Category
Stock Price
$2.32
Market Cap Chart
Since March 10, 2026, FreeCast's market cap has decreased from $373.03M to $94.79M, a decrease of -74.59%. That is a compound annual growth rate of -100.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 111.95M | -11.61% |
| Apr 20, 2026 | 126.66M | -11.68% |
| Apr 17, 2026 | 143.41M | -8.59% |
| Apr 16, 2026 | 156.89M | -3.03% |
| Apr 15, 2026 | 161.80M | -0.25% |
| Apr 14, 2026 | 162.20M | -0.75% |
| Apr 13, 2026 | 163.43M | 1.01% |
| Apr 10, 2026 | 161.80M | 1.02% |
| Apr 9, 2026 | 160.16M | -3.92% |
| Apr 8, 2026 | 166.70M | -3.32% |
| Apr 7, 2026 | 172.42M | -3.87% |
| Apr 6, 2026 | 179.36M | -2.44% |
| Apr 2, 2026 | 183.86M | 5.88% |
| Apr 1, 2026 | 173.64M | -4.71% |
| Mar 31, 2026 | 182.22M | 14.36% |
| Mar 30, 2026 | 159.34M | -2.01% |
| Mar 27, 2026 | 162.61M | -11.16% |
| Mar 26, 2026 | 183.04M | -0.22% |
| Mar 25, 2026 | 183.45M | 34.03% |
| Mar 24, 2026 | 136.87M | 7.01% |
| Mar 23, 2026 | 127.91M | 15.52% |
| Mar 20, 2026 | 110.72M | 6.69% |
| Mar 19, 2026 | 103.78M | 10.92% |
| Mar 18, 2026 | 93.56M | -4.58% |
| Mar 17, 2026 | 98.06M | -20.79% |
| Mar 16, 2026 | 123.80M | -36.48% |
| Mar 13, 2026 | 194.89M | -38.13% |
| Mar 12, 2026 | 315.01M | -3.63% |
| Mar 11, 2026 | 326.86M | -12.38% |
| Mar 10, 2026 | 373.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MDA Space | 3.43B |
| Versamet Royalties | 1.00B |
| Blue Moon Metals | 545.35M |
| CTW Cayman | 138.84M |
| JM Group | 134.27M |
| Meridian Holdings | 91.86M |
| Filana Therapeutics | 80.67M |
| Regentis Biomaterials | 16.31M |